Literature DB >> 10647170

Management of symptomatic lumbar pseudarthrosis with anteroposterior fusion. A functional and radiographic outcome study.

T J Albert1, M Pinto, F Denis.   

Abstract

STUDY
DESIGN: An independent retrospective review of 37 patients undergoing 39 anteroposterior lumbar fusions for lumbar pseudarthrosis repair between 1984 and 1990.
OBJECTIVES: To evaluate radiographically and functionally the results of the combined anteroposterior fusion for the management of symptomatic lumbar pseudarthrosis, and to assess risk factors for functional failure after the procedure. SUMMARY OF BACKGROUND DATA: Most reported techniques of pseudarthrosis repair involve posterior fusion with no instrumentation, posterior fusion with instrumentation, or anterior fusion alone. The results of lumbar pseudarthrosis repair are poor. Fusion rates range from 30% to 70%, with only a 30% to 50% rate of functional success.
METHODS: Thirty-nine procedures were assessed in 37 patients. The outcomes were assessed radiographically (solid fusion vs. pseudarthrosis) and functionally (success vs. failure). Radiographs were assessed at follow-up examination for consolidation of fusion anteriorly and posteriorly. Functional outcome was graded by using multiple instruments, including data from chart review and the follow-up outcome questionnaire. A functional failure score that took into account 10 items was developed.
RESULTS: In this patient population (37 patients, 59% with a smoking history, 71% with compensation or legal claims), there was a 10% pseudarthrosis rate. Pseudarthrosis was defined when one or more levels were involved and when it occurred anteriorly and posteriorly. In 12 patients (35%), the outcome was rated as functional failure. The presence of one or more abnormal neurologic findings and significant narcotic use before surgery significantly increased the chance of a patient's outcome being functional failure. Workmen's Compensation or legal status before surgery also increased the chance of functional failure, though this correlation was not statistically significant.
CONCLUSIONS: A combined anterior and posterior approach for the management of symptomatic lumbar pseudarthrosis is a viable alternative to posterior fusion alone. In fact, this procedure affords a higher fusion rate based on radiographic assessment. Functional failure rates may be decreased by using caution for those patients using narcotics regularly before surgery or in those with unexplained preoperative neurologic abnormal findings.

Entities:  

Mesh:

Year:  2000        PMID: 10647170     DOI: 10.1097/00007632-200001010-00021

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  15 in total

1.  Common surgical complications in degenerative spinal surgery.

Authors:  Michael Papadakis; Lianou Aggeliki; Elias C Papadopoulos; Federico P Girardi
Journal:  World J Orthop       Date:  2013-04-18

2.  A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.

Authors:  Alexander R Vaccaro; Tushar Patel; Jeffrey Fischgrund; D Greg Anderson; Eeric Truumees; Harry Herkowitz; Frank Phillips; Alan Hilibrand; Todd J Albert
Journal:  Eur Spine J       Date:  2005-01-26       Impact factor: 3.134

3.  Clinical and radiological outcome of anterior-posterior fusion versus transforaminal lumbar interbody fusion for symptomatic disc degeneration: a retrospective comparative study of 133 patients.

Authors:  Antonio A Faundez; James D Schwender; Yair Safriel; Thomas J Gilbert; Amir A Mehbod; Francis Denis; Ensor E Transfeldt; Jill M Wroblewski
Journal:  Eur Spine J       Date:  2009-01-06       Impact factor: 3.134

Review 4.  Fate of the adult revision spinal deformity patient: a single institution experience.

Authors:  Michael P Kelly; Lawrence G Lenke; Keith H Bridwell; Rashmi Agarwal; Jakub Godzik; Linda Koester
Journal:  Spine (Phila Pa 1976)       Date:  2013-09-01       Impact factor: 3.468

5.  A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.

Authors:  Alexander R Vaccaro; Tushar Patel; Jeffrey Fischgrund; D Greg Anderson; Eeric Truumees; Harry Herkowitz; Frank Phillips; Alan Hilibrand; Todd J Albert
Journal:  Eur Spine J       Date:  2003-08-08       Impact factor: 3.134

Review 6.  Surgical Strategies for the Treatment of Lumbar Pseudarthrosis in Degenerative Spine Surgery: A Literature Review and Case Study.

Authors:  Peter B Derman; Kern Singh
Journal:  HSS J       Date:  2019-10-30

7.  Predictors of Long-term Opioid Use Following Lumbar Fusion Surgery.

Authors:  Joseph Connolly; Zulqarnain Javed; Mukaila A Raji; Winston Chan; Yong-Fang Kuo; Jacques Baillargeon
Journal:  Spine (Phila Pa 1976)       Date:  2017-09-15       Impact factor: 3.241

8.  A 10-year follow-up of transpedicular screw fixation and intervertebral autogenous posterior iliac crest bone graft or intervertebral B-Twin system in failed back surgery syndrome.

Authors:  Rafael Cincu; Francisco de Asis Lorente; Joaquin Gomez; Jose Eiras; Amit Agrawal
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

9.  Posterior and anterior spinal fusion for the management of deformities in patients with Parkinson's disease.

Authors:  Masashi Sato; Takeshi Sainoh; Sumihisa Orita; Kazuyo Yamauchi; Yasuchika Aoki; Tetsuhiro Ishikawa; Masayuki Miyagi; Hiroto Kamoda; Miyako Suzuki; Gou Kubota; Yoshihiro Sakuma; Kazuhide Inage; Yasuhiro Oikawa; Junichi Nakamura; Masashi Takaso; Gen Inoue; Tomoaki Toyone; Kazuhisa Takahashi; Seiji Ohtori
Journal:  Case Rep Orthop       Date:  2013-09-02

Review 10.  Does Workers' Compensation Status Affect Outcomes after Lumbar Spine Surgery? A Systematic Review and Meta-Analysis.

Authors:  Fabrizio Russo; Sergio De Salvatore; Luca Ambrosio; Gianluca Vadalà; Luca Fontana; Rocco Papalia; Jorma Rantanen; Sergio Iavicoli; Vincenzo Denaro
Journal:  Int J Environ Res Public Health       Date:  2021-06-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.